EUVIMEDEUVIMED entdecken
LeitlinieOpen Access · CC BY-NC-ND 4.0

Clinical Application Guideline of Combination With Traditional Chinese Medicine and Western Medicine in the Prevention and Treatment of Chronic Obstructive Pulmonary Disease (2024)

Leitlinie zur klinischen Anwendung der Kombination aus Traditioneller Chinesischer Medizin und westlicher Medizin in der Prävention und Behandlung der chronisch obstruktiven Lungenerkrankung (2024)

Di Wu iD, Wei Liu, Jianxin Wang iD, Wei Chen, Mengyao Shi, Lu Zhang, Hui Wang, Huanzhang Ding, Xiao Ma, Yating Gao, Zengtao Sun, Jiangtao Lin und 6 weitere

Journal of Evidence-Based Medicine · 2025-06 · 18 (2)

DOI: 10.1111/jebm.70024 ↗

Auf einen Blick

Die Leitlinie fasst evidenzbasierte Empfehlungen zur COPD-Behandlung mit TCM und westlicher Medizin zusammen. Sie umfasst 9 klinische Fragen und 35 Empfehlungen.

Fragestellung

Entwicklung einer evidenzbasierten Leitlinie zur Behandlung der COPD mit chinesischer und westlicher Medizin.

Methode

Leitlinienentwicklung durch ein multidisziplinäres Panel; Literaturrecherche zu direkter Evidenz; Bewertung mit GRADE; Formulierung per Delphi-Methode.

Ergebnisse

Die Leitlinie deckt Diagnose und Behandlung der COPD ab, einschließlich Prinzipien, häufig verwendeter Medikamente, Komplikationen und Hochrisikogruppen. Enthalten sind 9 klinische Fragen und 35 Empfehlungen.

Schlussfolgerung der Autor:innen

Es handelt sich um eine umfassende und systematische evidenzbasierte Leitlinie, die Ärzt:innen bei der COPD-Behandlung unterstützen und die Versorgung verbessern soll.

Kernaussagen

  • 9 klinische Fragen und 35 Empfehlungen
  • Kombinationen aus TCM- und westlicher Medizin werden adressiert
  • Auch nichtmedikamentöse TCM-Verfahren wie Tai Chi und Baduanjin enthalten

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Leitlinie in der Zeitschrift Journal of Evidence-Based Medicine, online erschienen am 29.04.2025. Verfasst von Di Wu und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Traditional Chinese Medicine, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, China. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Medicine, Chinese Traditional, Drugs, Chinese Herbal. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Standardization Project of the "Clinical Application Guidelines for the Treatment of Diseases with Advantages in Traditional Chinese Medicine (TCM) Preparation…, National Administration of Traditional Chinese Medicine, National Health Commission's Healthy China Initiative's Key Project with Leading Roles and Responsibilities.

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Chronic Obstructive Pulmonary Disease (COPD) is a common chronic airway disease that can lead to decreased lung function in patients. It places a heavy economic burden on patients and society. Traditional Chinese medicine (TCM) and Western medicine have played important roles in managing COPD. We aimed to develop an evidence‐based guideline for treating COPD with Chinese and Western Medicine.

Methods

We formed a guideline panel of multidisciplinary experts. The clinical questions were identified based on two rounds of issue solicitation and expert demonstration. We searched the literature for direct evidence on the management of COPD and assessed its certainty‐generated evidence using the grading of recommendations, assessment, development, and evaluation (GRADE) approach. The recommendations and their strengths were formulated using the Delphi method.

Results

Our guideline covers aspects of the diagnosis and treatment of COPD such as principles and commonly used medications for both traditional Chinese medicine and Western medicine, complications, and the high‐risk populations. 9 clinical questions and 35 recommendations were identified, which covered the combinations of YuPingFeng granule, Buzhong Yiqi decoction, Gushen Dingchuan Pill, Bufei Huoxue Capsules, Runfei cream, Bailing Capsule, Tanyin Pills, etc., and nonpharmacological therapy of TCM such as combined acupoint application, electroacupuncture, and Chinese exercise techniques (Tai Chi, Baduanjin), etc. Recommendations were either high or low or in the form of ungraded consensus‐based statements.

Conclusions

This is a comprehensive and systematic evidence‐based guideline and we hope it can systematically and effectively guide clinicians in managing COPD and improve overall medical care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary Disease, Chronic ObstructiveMedicine, Chinese TraditionalDrugs, Chinese HerbalHumansEvidence-Based Medicine

Stichwörter der Autor:innen

chronic obstructive pulmonary diseaseevidence‐based guidelineintegrating Chinese and western medicinerecommendationtraditional Chinese medicine

Substanzen

Drugs, Chinese Herbal

Autor:innen und Institutionen

  • Department of Traditional Chinese Medicine, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, China.
  • Department of Integrated Traditional and Western Medicine, West China Hospital, Sichuan University, Chengdu, China.
  • Department of Evidence-Based Traditional Chinese Medicine, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
  • Centre for Evidence-Based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.
  • Department of Traditional Chinese Medicine, Anhui University of Chinese Medicine, Hefei, China.
  • The Affiliated First Hospital of Fuyang Normal University, Fuyang Normal University Fuyang Anhui, Fuyang, China.

ORCID-Profile: Di Wu, Jianxin Wang

Förderung

  • Standardization Project of the "Clinical Application Guidelines for the Treatment of Diseases with Advantages in Traditional Chinese Medicine (TCM) Preparation…
  • National Administration of Traditional Chinese Medicine
  • National Health Commission's Healthy China Initiative's Key Project with Leading Roles and Responsibilities
  • the Chinese Medicine Standardization Project of the Policy, Regulation and Supervision Department of the National Administration of Traditional Chinese Medicine
  • the National Natural Science Foundation of China
  • the Joint Fund for Regional Innovation and Development
  • the General Program of the National Natural Science Foundation of China

Zitieren

APA

Wu, D., Liu, W., Wang, J., Chen, W., Shi, M., Zhang, L., Wang, H., Ding, H., Ma, X., Gao, Y., Sun, Z., Lin, J., Zhang, H., Li, S., Li, Z., Lu, Z., Wen, F., & Li, Z. (2025). Clinical Application Guideline of Combination With Traditional Chinese Medicine and Western Medicine in the Prevention and Treatment of Chronic Obstructive Pulmonary Disease (2024). Journal of Evidence-Based Medicine, 18(2). https://doi.org/10.1111/jebm.70024

Vancouver

Wu D, Liu W, Wang J, Chen W, Shi M, Zhang L, et al. Clinical Application Guideline of Combination With Traditional Chinese Medicine and Western Medicine in the Prevention and Treatment of Chronic Obstructive Pulmonary Disease (2024). Journal of Evidence-Based Medicine. 2025;18(2). doi:10.1111/jebm.70024

BibTeX
@article{Wu2025,
  author = {Wu, Di and Liu, Wei and Wang, Jianxin and Chen, Wei and Shi, Mengyao and Zhang, Lu and Wang, Hui and Ding, Huanzhang and Ma, Xiao and Gao, Yating and Sun, Zengtao and Lin, Jiangtao and Zhang, Hongchun and Li, Suyun and Li, Zhuying and Lu, Zhenhui and Wen, Fuqiang and Li, Zegeng},
  title = {Clinical Application Guideline of Combination With Traditional Chinese Medicine and Western Medicine in the Prevention and Treatment of Chronic Obstructive Pulmonary Disease (2024)},
  journal = {Journal of Evidence-Based Medicine},
  year = {2025},
  volume = {18},
  number = {2},
  doi = {10.1111/jebm.70024}
}
Kostenlos starten →